Sessions Shaped By Member Preference Survey | ASRS 2025
Surveys of American Society of Retina Specialists members have revealed a preference for physicians’ experiences with new therapies, rather than summaries of clinical trial data, according to Gaurav K. Shah, M.D., program chair of ASRS 2025.
Sessions at the American Society of Retina Specialists 2025 meeting will focus on new study results rather than repetitive long-term study results, according to Gaurav K. Shah, M.D., program chair of ASRS 2025.
Shah cited member feedback from previous meetings.
“Our members have clearly stated to us that they're interested in new things, new trials, and new drugs,” Shah said in a recent video interview with Managed Healthcare Executive. “Physicians are interested in the results of an investigator-sponsored trial with a drug, rather than a rehash of a subgroup analysis.”
Gaurav K. Shah, M.D.
Shah drew on his experience as a physician. He currently practices ophthalmology at West Coast Retina, located in San Francisco.
“I would much rather believe, ‘I tried this drug on 64 patients of mine, and this is what I found,’ not what a statistician found.”
The 43rd annual ASRS takes place from July 30 to August 2, 2025, at the Long Beach Convention Center in Long Beach, California.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
